Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus

Journal of Clinical Investigation

Volumn 114, Issue 5, 2004, Pages 616-619

  Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; GLOMERULAR REACTIVE AUTOANTIBODY; UNCLASSIFIED DRUG;

COMPLEMENT ACTIVATION; GLOMERULONEPHRITIS; GLOMERULUS; INFLAMMATION; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; ORGAN INJURY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TARGET ORGAN; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; NOTE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 4944254502     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200422820     Document Type: Review

References (21)

1. Lachmann, P.J., and Hughes-Jones, N.C. 1984. Initiation of complement activation. Springer Semin. Immunopathol. 7:143-162.
2. Uwatoko, S., and Mannik, M. 1988. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J. Clin. Invest. 82:816-824.
3. Wisnieski, J.J., and Naff, G.B. 1989. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum. 32:1119-1127.
4. Coremans, I.E.M., et al. 1995. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 26:595-601.
5. Mannik, M., and Wener, M.H. 1997. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 40:1504-1511.
6. Trouw, L.A., et al. 2004. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 114:679-688. doi:10.1172/JCI200421075.
7. Quigg, R.J. 2004. Complement and autoimmune glomerular diseases. Curr. Dir. Autoimmun. 7:165-180.
8. Feintzeig, I.D., Dittmer, J.E., Cybulski, A.V., and Salant, D.J. 1986. Antibody, antigen, and glomerular capillary wall charge interactions: influence of antigen location on in situ immune complex formation. Kidney Int. 29:649-657.
9. Quigg, R.J., et al. 1998. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160:4553-4560.
10. Uwatoko, S., Gauthier, V.J., and Mannik, M. 1991. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin. Immunol. Immunopathol. 61:268-273.
11. Trouw, L.A., et al. 2003. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin. Exp. Immunol. 132:32-39.
12. Muller-Eberhard, H.J. 1988. Molecular organization and function of the complement system. Ann. Rev. Biochem. 57:321-347.
13. Liszewski, M.K., Farries, T.C., Lublin, D.M., Rooney, I.A., and Atkinson, J.P. 1996. Control of the complement system. Adv. Immunol. 61:201-283.
14. Girardi, G., et al. 2003. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112:1644-1654. doi:10.1172/JCI200318817.
15. Holers, V.M., and Thurman, J.M. 2004. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol. Immunol. 41:147-152.
16. Gigli, I., Sorvillo, J., Mecarelli-Halbwachs, L., and Leibowitch, J. 1981. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase. J. Exp. Med. 154:1-12.
17. Botto, M., et al. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59.
18. Bowness, P., et al. 1994. Hereditary C1q deficiency and systemic lupus erythematosus. Q. J. Med. 87:455-464.
19. Mitchell, D.A., et al. 2002. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168:2538-2543.
20. Mitchell, D.A., et al. 1999. C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162:5676-5679.
21. Botto, M., and Walport, M.J. 2002. C1q, autoimmunity and apoptosis. Immunobiology. 205:395-406.